Drug User Internet and Mobile Tech Use

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified February 2014 by Columbia University
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Crystal Fuller, PhD, MPH, Columbia University
ClinicalTrials.gov Identifier:
NCT01871298
First received: June 4, 2013
Last updated: February 25, 2014
Last verified: February 2014
  Purpose

The purpose of this exploratory study is to examine factors associated with frequency and type of internet and mobile technology use among illegal drug users, specifically use of internet and text-messaging to obtain health care information and engage in health care utilization, specifically human immunodeficiency virus (HIV) prevention and treatment services. We will target high drug activity neighborhoods in New York City and enroll participants recruited through targeted street outreach. All participants (n=336) will undergo an audio computer-assisted self-interview (ACASI) that will assess socio-demographics, health care access and utilization, sex/drug use behavior, health status, and characteristics of general and health-related internet/mobile technology use including factors that promote or hinder use. Participants identified as using the internet ≥1/month (n=151) will return for a 4-week ACASI to report on use of the pilot website (which will largely display information currently available in the community in print/ pamphlet/ video form).


Condition Intervention
Internet and Mobile Technology Use
Other: Pilot Health Website

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Exploratory Study of Drug User Health-related Internet and Mobile Technology Use

Resource links provided by NLM:


Further study details as provided by Columbia University:

Primary Outcome Measures:
  • Where drug users use internet and mobile technologies [ Time Frame: Baseline ] [ Designated as safety issue: No ]
  • Frequency of internet and mobile technology use [ Time Frame: Baseline ] [ Designated as safety issue: No ]
  • Reasons for using internet and mobile technologies [ Time Frame: Baseline ] [ Designated as safety issue: No ]
  • willingness to use internet or mobile technology for health-related purposes [ Time Frame: Baseline ] [ Designated as safety issue: No ]
  • actual internet or cell phone app/text message use for the purposes of acquiring health information and/or engaging the health care system [ Time Frame: Baseline ] [ Designated as safety issue: No ]
  • pilot website use [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
  • use of website functions [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
  • uptake in receipt of automatic text message updates on relevant health information [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 336
Study Start Date: February 2014
Estimated Study Completion Date: March 2015
Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Website access
While this pilot intervention is not a randomized trial, study participants who report internet use at least once a month will told of a pilot website that they will be able to access for a 4-week study period. This website will contain a educational information tailored to the health needs of drug users. Web content will be similar to materials and public health messages released by the NYC Department of Health and therefore, harm is not likely to arise from viewing such content.
Other: Pilot Health Website

The pilot health website will contain educational health information such as:

health-related videos, searchable map of HIV prevention and other needed health and social services, and the option to register for automatic text message updates on relevant health information.

No Intervention: No website access
Participants who report internet use less than once a month will not receive access to the pilot website.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • any illegal drug use in the past 6 months
  • age > 18.

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01871298

Contacts
Contact: Alexis Rivera, MPH avr2107@columbia.edu

Locations
United States, New York
Columbia University Medical Center Not yet recruiting
New York, New York, United States, 10032
Principal Investigator: Crystal Fuller, PhD         
Sponsors and Collaborators
Columbia University
Investigators
Principal Investigator: Crystal Fuller, PhD Department of Epidemiology, Columbia University Mailman School of Public Health
  More Information

No publications provided

Responsible Party: Crystal Fuller, PhD, MPH, Associate Professor of Clinical Epidemiology, Columbia University
ClinicalTrials.gov Identifier: NCT01871298     History of Changes
Other Study ID Numbers: AAAL6402
Study First Received: June 4, 2013
Last Updated: February 25, 2014
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on October 19, 2014